Unique molecules represent a emerging frontier in therapeutic development. Such short chains of amino residues provide unprecedented opportunities for engaging difficult targets involved in multiple conditions. Preliminary research indicate that can provide selective affinity and exhibit promising ADME features, opening ways to groundbreaking treat